Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes

FW. Miller, W. Chen, TP. O'Hanlon, RG. Cooper, J. Vencovsky, LG. Rider, K. Danko, LR. Wedderburn, IE. Lundberg, LM. Pachman, AM. Reed, SR. Ytterberg, L. Padyukov, A. Selva-O'Callaghan, TR. Radstake, DA. Isenberg, H. Chinoy, WE. Ollier, P. Scheet,...

. 2015 ; 16 (7) : 470-80. [pub] 20150820

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Intramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028292
E-zdroje Online Plný text

NLK ProQuest Central od 2000-02-01 do 2017-12-31
Open Access Digital Library od 1999-01-01
Medline Complete (EBSCOhost) od 1999-09-01 do 2015-10-31
Health & Medicine (ProQuest) od 2000-02-01 do 2017-12-31
Public Health Database (ProQuest) od 2000-02-01 do 2017-12-31

Odkazy

PubMed 26291516
DOI 10.1038/gene.2015.28
Knihovny.cz E-zdroje

Autoimmune muscle diseases (myositis) comprise a group of complex phenotypes influenced by genetic and environmental factors. To identify genetic risk factors in patients of European ancestry, we conducted a genome-wide association study (GWAS) of the major myositis phenotypes in a total of 1710 cases, which included 705 adult dermatomyositis, 473 juvenile dermatomyositis, 532 polymyositis and 202 adult dermatomyositis, juvenile dermatomyositis or polymyositis patients with anti-histidyl-tRNA synthetase (anti-Jo-1) autoantibodies, and compared them with 4724 controls. Single-nucleotide polymorphisms showing strong associations (P<5×10(-8)) in GWAS were identified in the major histocompatibility complex (MHC) region for all myositis phenotypes together, as well as for the four clinical and autoantibody phenotypes studied separately. Imputation and regression analyses found that alleles comprising the human leukocyte antigen (HLA) 8.1 ancestral haplotype (AH8.1) defined essentially all the genetic risk in the phenotypes studied. Although the HLA DRB1*03:01 allele showed slightly stronger associations with adult and juvenile dermatomyositis, and HLA B*08:01 with polymyositis and anti-Jo-1 autoantibody-positive myositis, multiple alleles of AH8.1 were required for the full risk effects. Our findings establish that alleles of the AH8.1 comprise the primary genetic risk factors associated with the major myositis phenotypes in geographically diverse Caucasian populations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028292
003      
CZ-PrNML
005      
20190124083018.0
007      
ta
008      
161005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/gene.2015.28 $2 doi
024    7_
$a 10.1038/gene.2015.28 $2 doi
035    __
$a (PubMed)26291516
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miller, F W $u National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
245    10
$a Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes / $c FW. Miller, W. Chen, TP. O'Hanlon, RG. Cooper, J. Vencovsky, LG. Rider, K. Danko, LR. Wedderburn, IE. Lundberg, LM. Pachman, AM. Reed, SR. Ytterberg, L. Padyukov, A. Selva-O'Callaghan, TR. Radstake, DA. Isenberg, H. Chinoy, WE. Ollier, P. Scheet, B. Peng, A. Lee, J. Byun, JA. Lamb, PK. Gregersen, CI. Amos, . ,
520    9_
$a Autoimmune muscle diseases (myositis) comprise a group of complex phenotypes influenced by genetic and environmental factors. To identify genetic risk factors in patients of European ancestry, we conducted a genome-wide association study (GWAS) of the major myositis phenotypes in a total of 1710 cases, which included 705 adult dermatomyositis, 473 juvenile dermatomyositis, 532 polymyositis and 202 adult dermatomyositis, juvenile dermatomyositis or polymyositis patients with anti-histidyl-tRNA synthetase (anti-Jo-1) autoantibodies, and compared them with 4724 controls. Single-nucleotide polymorphisms showing strong associations (P<5×10(-8)) in GWAS were identified in the major histocompatibility complex (MHC) region for all myositis phenotypes together, as well as for the four clinical and autoantibody phenotypes studied separately. Imputation and regression analyses found that alleles comprising the human leukocyte antigen (HLA) 8.1 ancestral haplotype (AH8.1) defined essentially all the genetic risk in the phenotypes studied. Although the HLA DRB1*03:01 allele showed slightly stronger associations with adult and juvenile dermatomyositis, and HLA B*08:01 with polymyositis and anti-Jo-1 autoantibody-positive myositis, multiple alleles of AH8.1 were required for the full risk effects. Our findings establish that alleles of the AH8.1 comprise the primary genetic risk factors associated with the major myositis phenotypes in geographically diverse Caucasian populations.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    12
$a alely $7 D000483
650    _2
$a autoprotilátky $x imunologie $7 D001323
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dermatomyozitida $x genetika $7 D003882
650    _2
$a běloši $7 D044465
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a HLA antigeny $x genetika $7 D006680
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a myozitida $x genetika $7 D009220
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a polymyozitida $x genetika $7 D017285
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chen, W $u M.D. Anderson Cancer Center, Houston, TX, USA.
700    1_
$a O'Hanlon, T P $u National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Cooper, R G $u MRC/ARUK Institute for Ageing and Chronic Disease, University of Liverpool, UK.
700    1_
$a Vencovsky, J $u Institute of Rheumatology, Charles University, Prague, Czech Republic.
700    1_
$a Rider, L G $u National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
700    1_
$a Danko, K $u 3rd Department of Internal Medicine, Division of Immunology University of Debrecen, Debrecen, Hungary.
700    1_
$a Wedderburn, L R $u Institute of Child Health, University College London, London, UK.
700    1_
$a Lundberg, I E $u Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Pachman, L M $u Department of Pediatric Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
700    1_
$a Reed, A M $u Mayo Clinic, Rochester, MN, USA.
700    1_
$a Ytterberg, S R $u Mayo Clinic, Rochester, MN, USA.
700    1_
$a Padyukov, L $u Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Selva-O'Callaghan, A $u Vall d'Hebron General Hospital, Barcelona, Spain.
700    1_
$a Radstake, T R $u Department of Rheumatology and Clinical Immunology, Laboratory for Translational Immunology, Utrecht University Medical Center; and Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands.
700    1_
$a Isenberg, David $d 1949- $7 xx0231548 $u Division of Medicine, University College London, London, UK.
700    1_
$a Chinoy, H $u The National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
700    1_
$a Ollier, W E R $u Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
700    1_
$a Scheet, P $u M.D. Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Peng, B $u M.D. Anderson Cancer Center, Houston, TX, USA.
700    1_
$a Lee, A $u Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, USA.
700    1_
$a Byun, J $u Department of Community and Family Medicine, Dartmouth College, Hanover, NH, USA.
700    1_
$a Lamb, J A $u Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
700    1_
$a Gregersen, P K $u Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, USA.
700    1_
$a Amos, C I $u Department of Community and Family Medicine, Dartmouth College, Hanover, NH, USA. $7 gn_A_00005727
700    1_
$a ,
773    0_
$w MED00007954 $t Genes and immunity $x 1476-5470 $g Roč. 16, č. 7 (2015), s. 470-80
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26291516 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20190124083240 $b ABA008
999    __
$a ok $b bmc $g 1166606 $s 952922
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 16 $c 7 $d 470-80 $e 20150820 $i 1476-5470 $m Genes and immunity $n Genes Immun $x MED00007954
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace